The first stop for professional medicines advice

COVID-19 Medicines Optimisation: Specialty Guidance

28 results

RelevanceNewest firstOldest firstTitle
Applied filters

Summary of COVID-19 medicines guidance: Skin disorders

12 January 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and skin disorders. Our advice…

Summary of COVID-19 medicines guidance: Later life

12 January 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and later life disorders. Our…

Summary of COVID-19 medicines guidance: Diabetes

12 January 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and diabetes. Our advice is…

Summary of COVID-19 medicines guidance: Critical care

12 January 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and critical care. Our advice…

Summary of COVID-19 medicines guidance: Allergy and immunology

7 January 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and allergy and immunology conditions.…

Summary of COVID-19 medicines guidance: Haematological disorders

6 January 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and haematological disorders. Our advice…

Summary of COVID-19 medicines guidance: Family planning

6 January 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and family planning. Our advice…

Summary of COVID-19 medicines guidance: Obstetrics and gynaecology

6 January 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and obstetrics and gynaecology. Our…

Summary of COVID-19 medicines guidance: Mental health and illness

6 January 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and mental health and illness.…

Summary of COVID-19 medicines guidance: Policy, Commissioning and Managerial

5 January 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to Policy and Commissioning during coronavirus pandemic.…